Esperion Therapeutics ROA 2012-2018 | ESPR

Current and historical return on assets (ROA) values for Esperion Therapeutics (ESPR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Esperion Therapeutics ROA for the three months ending September 30, 2018 was -79.24%.
Esperion Therapeutics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.18B $0.17B -79.38%
2018-06-30 $-0.18B $0.21B -66.92%
2018-03-31 $-0.17B $0.24B -67.45%
2017-12-31 $-0.17B $0.28B -67.41%
2017-09-30 $-0.16B $0.31B -65.97%
2017-06-30 $-0.13B $0.19B -57.21%
2017-03-31 $-0.10B $0.22B -40.36%
2016-12-31 $-0.08B $0.25B -27.99%
2016-09-30 $-0.06B $0.26B -21.02%
2016-06-30 $-0.06B $0.28B -18.88%
2016-03-31 $-0.05B $0.29B -17.61%
2015-12-31 $-0.05B $0.30B -15.77%
2015-09-30 $-0.05B $0.31B -16.51%
2015-06-30 $-0.04B $0.32B -19.88%
2015-03-31 $-0.04B $0.33B -26.09%
2014-12-31 $-0.04B $0.14B -41.98%
2014-09-30 $-0.04B $0.06B -53.24%
2014-06-30 $-0.03B $0.07B -42.11%
2014-03-31 $-0.03B $0.07B -47.06%
2013-12-31 $-0.03B $0.08B -56.22%
2013-09-30 $-0.02B $0.09B -59.81%
2013-06-30 $-0.01B $0.02B -280.00%
2013-03-31 $-0.01B $0.00B inf%
2012-12-31 $-0.01B $0.00B -1200.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.418B $0.000B
Esperion Therapeutics, Inc. is a biopharmaceutical company. It focused on the research, development and commercialization of therapies for low-density lipoprotein cholesterol and other cardiometabolic risk factors. Esperion Therapeutics, Inc. is based in Plymouth, Michigan.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $51.794B 11.05
Zoetis (ZTS) United States $43.144B 29.54
Grifols (GRFS) Spain $12.851B 15.68
Tilray (TLRY) United States $8.764B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.468B 12.15
Neurocrine Biosciences (NBIX) United States $7.777B 1715.20
Ionis Pharmaceuticals (IONS) United States $7.422B 0.00
Nektar Therapeutics (NKTR) United States $6.306B 9.04
Catalent (CTLT) United States $5.273B 22.12
Sage Therapeutics (SAGE) United States $5.056B 0.00
Impax Laboratories (AMRX) United States $4.974B 26.44
United Therapeutics (UTHR) United States $4.785B 7.83
Loxo Oncology (LOXO) United States $4.206B 0.00
TESARO (TSRO) United States $4.087B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.489B 12.92
FibroGen (FGEN) United States $3.379B 0.00
USANA Health Sciences (USNA) United States $2.908B 24.75
Endo (ENDP) Ireland $2.515B 3.85
Xencor (XNCR) United States $2.110B 0.00
Heron Therapeutics (HRTX) United States $2.102B 0.00
Corcept Therapeutics (CORT) United States $1.983B 29.10
Endocyte (ECYT) United States $1.957B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.932B 261.11
Ironwood Pharmaceuticals (IRWD) United States $1.873B 0.00
Aerie Pharmaceuticals (AERI) United States $1.842B 0.00
Zogenix (ZGNX) United States $1.832B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.765B 0.00
PTC Therapeutics (PTCT) United States $1.749B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.538B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.438B 20.23
Spectrum Pharmaceuticals (SPPI) United States $1.368B 0.00
Tricida (TCDA) United States $1.361B 0.00
Portola Pharmaceuticals (PTLA) United States $1.295B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.199B 0.00
TherapeuticsMD (TXMD) United States $1.006B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.976B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.814B 0.00
ImmunoGen (IMGN) United States $0.805B 0.00
Radius Health (RDUS) United States $0.743B 0.00
Karyopharm Therapeutics (KPTI) United States $0.625B 0.00
Collegium Pharmaceutical (COLL) United States $0.618B 0.00
Forty Seven (FTSV) United States $0.582B 0.00
Flexion Therapeutics (FLXN) United States $0.544B 0.00
Akebia Therapeutics (AKBA) United States $0.522B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.517B 0.00
ChemoCentryx (CCXI) United States $0.510B 40.40
Siga Technologies (SIGA) United States $0.489B 0.00
Dermira (DERM) United States $0.462B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.460B 0.00
GlycoMimetics (GLYC) United States $0.458B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.445B 26.23
Dova Pharmaceuticals (DOVA) United States $0.436B 0.00
Tyme Technologies (TYME) United States $0.425B 0.00
Xeris Pharmaceuticals (XERS) United States $0.421B 0.00
Translate Bio (TBIO) United States $0.409B 0.00
Odonate Therapeutics (ODT) United States $0.409B 0.00
KalVista Pharmaceuticals (KALV) United States $0.398B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.395B 0.00
ArQule (ARQL) United States $0.377B 0.00
CASI Pharmaceuticals (CASI) United States $0.370B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.367B 0.00
Majesco Entertainment (PTE) United States $0.358B 0.00
Aclaris Therapeutics (ACRS) United States $0.336B 0.00
Tapimmune (MRKR) United States $0.328B 0.00
OptiNose (OPTN) United States $0.321B 0.00
Minerva Neurosciences (NERV) United States $0.309B 0.00
Aratana Therapeutics (PETX) United States $0.307B 0.00
Concert Pharmaceuticals (CNCE) United States $0.306B 0.00
Depomed (ASRT) United States $0.270B 10.05
Mast Therapeutics (SVRA) United States $0.267B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.257B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.255B 0.00
IMV INC (IMV) Canada $0.250B 0.00
Aldeyra Therapeutics (ALDX) United States $0.249B 0.00
Ocular Therapeutix (OCUL) United States $0.240B 0.00
Affimed (AFMD) Germany $0.227B 0.00
Aquestive Therapeutics (AQST) United States $0.214B 0.00
Galectin Therapeutics (GALT) United States $0.210B 0.00
Lannett Co Inc (LCI) United States $0.207B 1.79
Foamix Pharmaceuticals (FOMX) Israel $0.207B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.207B 0.00
Zafgen (ZFGN) United States $0.195B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.195B 0.00
TAIWAN LIPOSOME (TLC) Taiwan $0.194B 0.00
Opexa Therapeutics (ACER) United States $0.193B 0.00
Calithera Biosciences (CALA) United States $0.185B 0.00
MEI Pharma (MEIP) United States $0.175B 0.00
Nature's Sunshine Products (NATR) United States $0.172B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.170B 0.00
Recro Pharma (REPH) United States $0.168B 0.00
ContraFect (CFRX) United States $0.160B 0.00
Neon Therapeutics (NTGN) United States $0.159B 0.00
Molecular Templates (MTEM) United States $0.156B 0.00
Ardelyx (ARDX) United States $0.151B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.151B 0.00
Redhill Biopharma (RDHL) Israel $0.149B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.144B 0.00
ElectroCore (ECOR) United States $0.140B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.139B 0.00
MediWound (MDWD) Israel $0.138B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.126B 0.00
Cardiome Pharma (CORV) Canada $0.126B 0.00
DURECT (DRRX) United States $0.121B 0.00
Jounce Therapeutics (JNCE) United States $0.121B 0.00
Adherex Technologies (FENC) United States $0.119B 0.00
Champions Oncology (CSBR) United States $0.114B 0.00
Rafael Holdings (RFL) United States $0.113B 0.00
ProNAi Therapeutics (SRRA) Canada $0.108B 0.00
Iterum Therapeutics (ITRM) Ireland $0.103B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.094B 0.00
Immune Design (IMDZ) United States $0.093B 0.00
CTI BioPharma (CTIC) United States $0.087B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.086B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.086B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.084B 0.00
Achaogen (AKAO) United States $0.080B 0.00
Melinta Therapeutics (MLNT) United States $0.078B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.078B 0.00
Natural Alternatives (NAII) United States $0.078B 7.68
Otonomy (OTIC) United States $0.077B 0.00
KemPharm (KMPH) United States $0.074B 0.00
Infinity Pharmaceuticals (INFI) United States $0.072B 0.00
BioLineRx (BLRX) Israel $0.069B 0.00
Nivalis Therapeutics (ALPN) United States $0.068B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.061B 37.86
Neos Therapeutics (NEOS) United States $0.060B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.058B 0.00
Avenue Therapeutics (ATXI) United States $0.056B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.051B 0.00
Genocea Biosciences (GNCA) United States $0.050B 0.00
Mannatechorporated (MTEX) United States $0.048B 0.00
Forward Pharma (FWP) Denmark $0.048B 0.00
Novan (NOVN) United States $0.039B 0.00
Capnia (SLNO) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.036B 4.08
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Trillium Therapeutics (TRIL) Canada $0.032B 0.00
Heat Biologics (HTBX) United States $0.031B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.030B 0.00
Lipocine (LPCN) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
IsoRay (ISR) United States $0.027B 0.00
PharmAthene (ALT) United States $0.027B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
NanoViricides (NNVC) United States $0.023B 0.00
Biomerica (BMRA) United States $0.023B 0.00
HANCOCK JAFFE (HJLI) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.021B 0.00
Jaguar Animal Health (JAGX) United States $0.019B 0.00
Aviragen Therapeutics (VXRT) United States $0.019B 0.00
Onconova Therapeutics (ONTX) United States $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 6.35
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
ESSA Pharma (EPIX) Canada $0.016B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 1.49
DelMar Pharmaceuticals (DMPI) Canada $0.011B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.010B 0.00
Aradigm (ARDM) United States $0.010B 0.00
Skyline Medical (AIPT) United States $0.009B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
AGEX THERAPEUTC (AGE) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00